2024 Publications

Go to main research page / previous years

The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis. (2024) Millington, K. A., White, R. G., Lipman, M., McQuaid, C. F., Hauser, J., Wooding, V., Potter, J., Abubakar, I., and Wingfield, T. Lancet Respir Med 12, 10-13: https://doi.org/10.1016/S2213-2600(23)00409-5.

Acetic acid enables molecular enumeration of Mycobacterium tuberculosis from sputum and eliminates the need for a biosafety level 3 laboratory. (2024) Palekyte, A., Morkowska, A., Billington, O., Morris-Jones, S., Millard, J., Marakalala, M. J., Owolabi, O., Sambou, B., Zumla, A., Sutherland, J. S., McHugh, T. D., and Honeyborne, I. Clin Chem 70, 642-652: https://doi.org/10.1093/clinchem/hvae013.

Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial. (2024) Palmer, M., van der Zalm, M. M., Schaaf, H. S., Goussard, P., Morrison, J., Seddon, J. A., Hissar, S., Baskaran, D., Kinikar, A., Raichur, P., Wobudeya, E., Chabala, C., Lebeau, K., Crook, A. M., Turkova, A., Gibb, D., and Hesseling, A. C. Int J Tuberc Lung Dis 28, 547-553: https://doi.org/10.5588/ijtld.24.0076.

Assessing efficacy in non-inferiority trials with non-adherence to interventions: Are intention-to-treat and per-protocol analyses fit for purpose? (2024) Dodd, M., Carpenter, J., Thompson, J. A., Williamson, E., Fielding, K., and Elbourne, D. Stat Med 43, 2314-2331: https://doi.org/10.1002/sim.10067.

Assessing the effect of health system resources on HIV and tuberculosis programmes in Malawi: a modelling study. (2024) Mangal, T. D., Mohan, S., Colbourn, T., Collins, J. H., Graham, M., Jahn, A., Janouskova, E., Lin, I. L., Smith, R. M., Mnjowe, E., Molaro, M., Mwenyenkulu, T. E., Nkhoma, D., She, B., Tamuri, A., Revill, P., Phillips, A. N., Mfutso-Bengo, J., and Hallett, T. B. Lancet Glob Health 12, e1638-e1648: https://doi.org/10.1016/S2214-109X(24)00259-6.

Association between tobacco smoking and prevalence of HIV, tuberculosis, hypertension and diabetes in rural South Africa: a cross-sectional study. (2024) Chidumwa, G., Olivier, S., Ngubane, H., Zulu, T., Sithole, M., Gunda, R., Vukuzazi, T., Sewpaul, R., Kruse, G., Rigotti, N. A., Hanekom, W. A., Siedner, M. J., Reddy, K. P., and Wong, E. B. BMC Public Health 24, 3306: https://doi.org/10.1186/s12889-024-20791-4.

B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles. (2024) Krause, R., Ogongo, P., Tezera, L., Ahmed, M., Mbano, I., Chambers, M., Ngoepe, A., Magnoumba, M., Muema, D., Karim, F., Khan, K., Lumamba, K., Nargan, K., Madansein, R., Steyn, A., Shalek, A. K., Elkington, P., and Leslie, A. Commun Biol 7, 584: https://doi.org/10.1038/s42003-024-06282-7.

BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery. (2024) Bonjorno, A. F., Pavan, A. R., Fernandes, G. F. S., Scarim, C. B., Castagnolo, D., and Dos Santos, J. L. Front Chem 12, 1358539: https://doi.org/10.3389/fchem.2024.1358539.

Bedaquiline: what might the future hold? (2024) Shaw, E. S., Stoker, N. G., Potter, J. L., Claassen, H., Leslie, A., Tweed, C. D., Chiang, C. Y., Conradie, F., Esmail, H., Lange, C., Pinto, L., Rucsineanu, O., Sloan, D. J., Theron, G., Tisile, P., Voo, T. C., Warren, R. M., Lebina, L., and Lipman, M. Lancet Microbe 5, 100909: https://doi.org/10.1016/S2666-5247(24)00149-6.

Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. (2024) Cevik, M., Thompson, L. C., Upton, C., Rolla, V. C., Malahleha, M., Mmbaga, B., Ngubane, N., Abu Bakar, Z., Rassool, M., Variava, E., Dawson, R., Staples, S., Lalloo, U., Louw, C., Conradie, F., Eristavi, M., Samoilova, A., Skornyakov, S. N., Ntinginya, N. E., Haraka, F., Praygod, G., Mayanja-Kizza, H., Caoili, J., Balanag, V., Dalcolmo, M. P., McHugh, T., Hunt, R., Solanki, P., Bateson, A., Crook, A. M., Fabiane, S., Timm, J., Sun, E., Spigelman, M., Sloan, D. J., Gillespie, S. H., and Simplici, T. B. C. Lancet Infect Dis 24, 1003-1014: https://doi.org/10.1016/S1473-3099(24)00223-8.

Bioarchaeological investigation of individuals with suspected multibacillary leprosy from the mediaeval leprosarium of St Mary Magdalen, Winchester, Hampshire, UK. (2024) Taylor, G. M., White-Iribhogbe, K., Cole, G., Ashby, D., Stewart, G. R., and Dawson-Hobbis, H. J Med Microbiol 73 https://doi.org/10.1099/jmm.0.001806.

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa. (2024) Riitho, V., Connon, R., Gwela, A., Namusanje, J., Nhema, R., Siika, A., Bwakura-Dangarembizi, M., Musiime, V., Berkley, J. A., Szubert, A. J., Gibb, D. M., Walker, A. S., Klein, N., and Prendergast, A. J. Nat Commun 15, 5492: https://doi.org/10.1038/s41467-024-49317-7.

Blazing the trail for innovative tuberculosis diagnostics. (2024) Yerlikaya, S., Broger, T., Isaacs, C., Bell, D., Holtgrewe, L., Gupta-Wright, A., Nahid, P., Cattamanchi, A., and Denkinger, C. M. Infection 52, 29-42: https://doi.org/10.1007/s15010-023-02135-3.

Blood RNA biomarkers for tuberculosis screening in people living with HIV before antiretroviral therapy initiation: A diagnostic accuracy study. (2024) Mann, T., Gupta, R. K., Reeve, B. W. P., Ndlangalavu, G., Chandran, A., Krishna, A. P., Calderwood, C. J., Tshivhula, H., Palmer, Z., Naidoo, S., Mbu, D. L., Theron, G., and Noursadeghi, M. Lancet Glob Health 12, e783-e792: https://doi.org/10.1016/S2214-109X(24)00029-9.

Characteristics and phenotypes of a COPD cohort from referral hospital clinics in Uganda. (2024) Alupo, P., Mugenyi, L., Katagira, W., Kayongo, A., Nalunjogi, J., Siddharthan, T., Hurst, J. R., Kirenga, B., and Jones, R. BMJ Open Respir Res 11 https://doi.org/10.1136/bmjresp-2023-001816.

Characterizing the immune response to Mycobacterium tuberculosis: a comprehensive narrative review and implications in disease relapse. (2024) Rahman, F. Front Immunol 15, 1437901: https://doi.org/10.3389/fimmu.2024.1437901.

Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. (2024) Coussens, A. K., Zaidi, S. M. A., Allwood, B. W., Dewan, P. K., Gray, G., Kohli, M., Kredo, T., Marais, B. J., Marks, G. B., Martinez, L., Ruhwald, M., Scriba, T. J., Seddon, J. A., Tisile, P., Warner, D. F., Wilkinson, R. J., Esmail, H., Houben, R., and International Consensus for Early, T. B. g. Lancet Respir Med 12, 484-498: https://doi.org/10.1016/S2213-2600(24)00028-6.

Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report. (2024) Katale, B. Z., Rofael, S., Elton, L., Mbugi, E. V., Mpagama, S. G., Mtunga, D., Mafie, M. G., Mbelele, P. M., Williams, C., Mvungi, H. C., Williams, R., Saku, G. A., Ruta, J. A., McHugh, T. D., and Matee, M. I. Ann Clin Microbiol Antimicrob 23, 76: https://doi.org/10.1186/s12941-024-00737-9.

Clinical outcomes in children with human immunodeficiency virus treated for nonsevere tuberculosis in the SHINE trial. (2024) Chabala, C., Wobudeya, E., van der Zalm, M. M., Kapasa, M., Raichur, P., Mboizi, R., Palmer, M., Kinikar, A., Hissar, S., Mulenga, V., Mave, V., Musoke, P., Hesseling, A. C., McIlleron, H., Gibb, D., Crook, A., Turkova, A., and Team, S. T. Clin Infect Dis 79, 70-77: https://doi.org/10.1093/cid/ciae193.

Combined analysis of host IFN-gamma, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood. (2024) Rapulana, A. M., Mpotje, T., Baiyegunhi, O. O., Ndlovu, H., Smit, T. K., McHugh, T. D., and Marakalala, M. J. Front Mol Med 4, 1345510: https://doi.org/10.3389/fmmed.2024.1345510.

Community views on active case finding for tuberculosis in low- and middle-income countries: a qualitative evidence synthesis. (2024) Taylor, M., Medley, N., van Wyk, S. S., and Oliver, S. Cochrane Database Syst Rev 3, CD014756: https://doi.org/10.1002/14651858.CD014756.pub2.

Community-based active-case finding for tuberculosis: navigating a complex minefield. (2024) MacPherson, P., Shanaube, K., Phiri, M. D., Rickman, H. M., Horton, K. C., Feasey, H. R. A., Corbett, E. L., Burke, R. M., and Rangaka, M. X. BMC Glob Public Health 2, 9: https://doi.org/10.1186/s44263-024-00042-9.

Comparative efficacy and safety of moxifloxacin and levofloxacin in a short standardised rifampicin resistant TB regimen: A STREAM 2 secondary analysis. (2024) Fabiane, S. M., Chiang, C. Y., Meredith, S. K., Gurumurthy, M., Bayissa, A., Nunn, A. J., Goodall, R. L., and Collaborators, S. Trop Med Infect Dis 9 https://doi.org/10.3390/tropicalmed9090211.

Comparing priority received by global health issues: a measurement framework applied to tuberculosis, malaria, diarrhoeal diseases and dengue fever. (2024) Parashar, R., Nanda, S., Smith, S. L., Shroff, Z., Shawar, Y. R., Hamunakwadi, D. L., and Shiffman, J. BMJ Glob Health 9 https://doi.org/10.1136/bmjgh-2023-014884.

Confounding undermines inferences of preventive therapy effectiveness among subgroups of tuberculosis contacts. (2024) Greenan-Barrett, J., Hamada, Y., Fielding, K. L., Noursadeghi, M., and Gupta, R. K. Lancet Respir Med 12, e57-e58: https://doi.org/10.1016/S2213-2600(24)00292-3.

Correction: Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol. (2024) Neudecker, D., Fritschi, N., Sutter, T., Lu, L. L., Lu, P., Tebruegge, M., Santiago-Garcia, B., and Ritz, N. BMC Infect Dis 24, 629: https://doi.org/10.1186/s12879-024-09432-8.

Cost-effectiveness of diagnostic technologies for Mycobacterium tuberculosis infection in India and Brazil. (2024) Bashir, S., Ali, S., Yerlikaya, S., Gaeddert, M., Gosce, L., Rangaka, M. X., and C, M. D. PLOS Glob Public Health 4, e0003638: https://doi.org/10.1371/journal.pgph.0003638.

Design and synthesis of pyridyl and 2-hydroxyphenyl chalcones with antitubercular activity. (2024) Aziafor, K., Ruparelia, K., Moulds, B., Zloh, M., Parish, T., and Brucoli, F. Molecules 29 https://doi.org/10.3390/molecules29194539.

Detailed phenotyping reveals diverse and highly skewed neutrophil subsets in both the blood and airways during active tuberculosis infection. (2024) Nhamoyebonde, S., Chambers, M., Ndlovu, L., Karim, F., Mazibuko, M., Mhlane, Z., Madziwa, L., Moosa, Y., Moodley, S., Hoque, M., and Leslie, A. Front Immunol 15, 1422836: https://doi.org/10.3389/fimmu.2024.1422836.

Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis. (2024) Nimmo, C., Ortiz, A. T., Tan, C. C. S., Pang, J., Acman, M., Millard, J., Padayatchi, N., Grant, A. D., O'Donnell, M., Pym, A., Brynildsrud, O. B., Eldholm, V., Grandjean, L., Didelot, X., Balloux, F., and van Dorp, L. Genome Med 16, 34: https://doi.org/10.1186/s13073-024-01289-5.

Detection of M. tuberculosis DNA in peripheral blood mononuclear cells of tuberculosis contacts does not associate with blood RNA signatures for incipient tuberculosis. (2024) Rosenheim, J., Abebe, M., Belay, M., Tulu, B., Tayachew, D., Tegegn, M., Younis, S., Jolliffe, D. A., Aseffa, A., Ameni, G., Reece, S. T., Noursadeghi, M., and Martineau, A. R. Eur Respir J 64 https://doi.org/10.1183/13993003.00479-2024.

Diagnosis and management of tuberculosis infection in inclusion health populations in London. (2024) Gray, A., Surey, J., Veitch, M., Menezes, D., Gibbons, J., Leonard, M., Sultan, B., Esmail, H., and Story, A. BMC Infect Dis 24, 252: https://doi.org/10.1186/s12879-024-09132-3.

Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study. (2024) Fritschi, N., Gureva, T., Eliseev, P., Jackson, C., Milanzi, E., Crichton, S., Collins, I. J., Turkova, A., Mariandyshev, A., and Ritz, N. PLoS One 19, e0293272: https://doi.org/10.1371/journal.pone.0293272.

Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries. (2024) Olbrich, L., Verghese, V. P., Franckling-Smith, Z., Sabi, I., Ntinginya, N. E., Mfinanga, A., Banze, D., Viegas, S., Khosa, C., Semphere, R., Nliwasa, M., McHugh, T. D., Larsson, L., Razid, A., Song, R., Corbett, E. L., Nabeta, P., Trollip, A., Graham, S. M., Hoelscher, M., Geldmacher, C., Zar, H. J., Michael, J. S., Heinrich, N., and RaPaed, T. B. c. Lancet Infect Dis 24, 140-149: https://doi.org/10.1016/S1473-3099(23)00491-7.

Diagnostic accuracy of chest X-ray computer-aided detection software for detection of prevalent and incident tuberculosis in household contacts. (2024) Macpherson, L., Kik, S. V., Quartagno, M., Lakay, F., Jaftha, M., Yende, N., Galant, S., Aziz, S., Daroowala, R., Court, R., Taliep, A., Serole, K., Goliath, R. T., Davies, N. O., Jackson, A., Douglass, E., Sossen, B., Mukasa, S., Thienemann, F., Song, T., Ruhwald, M., Wilkinson, R. J., Coussens, A. K., Esmail, H., and Imaging of, T. B. H. C. G. Clin Infect Dis https://doi.org/10.1093/cid/ciae528.

Diagnostic potential of combining plasma biomarkers of tissue damage and inflammation in pediatric TB. (2024) Lopez-Suarez, A., Santos-Sebastian, M., Hernanz-Lobo, A., Rincon-Lopez, E., Aguilera-Alonso, D., Saavedra-Lozano, J., Ruiz Serrano, M. J., Hernandez-Bartolome, A., Medrano de Dios, L. M., Jimenez Fuentes, J. L., Navarro, M. L., Tebruegge, M., and Santiago-Garcia, B. J Microbiol Immunol Infect 57, 937-946: https://doi.org/10.1016/j.jmii.2024.07.011.

Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection. (2024) Cho, F. N., Achidi, E. A., Enoh, J. E., Pallerla, S. R., Linh, L. T. K., Tong, H. V., Kamgno, J., Penlap, V. B., Adegnika, A. A., Lekana-Douki, J. B., Bouyou-Akotet, M. K., Kahunu, G. M., Lutete, G. T., Bates, M., Tembo, J., Elton, L., McHugh, T. D., Grobusch, M. P., Zumla, A., Ntoumi, F., and Velavan, T. P. BMC Infect Dis 24, 759: https://doi.org/10.1186/s12879-024-09638-w.

Drug-resistant tuberculosis treatments, the case for a phase III platform trial. (2024) Yates, T. A., Barnes, S., Dedicoat, M., Kon, O. M., Kunst, H., Lipman, M., Millington, K. A., Nunn, A. J., Phillips, P. P., Potter, J. L., Squire, S. B., Academics, U. K., and Professionals to end, T. B. Bull World Health Organ 102, 657-664: https://doi.org/10.2471/BLT.23.290948.

Duckweeds as edible vaccines in the animal farming industry. (2024) Sembada, A. A., Theda, Y., and Faizal, A. 3 Biotech 14, 222: https://doi.org/10.1007/s13205-024-04074-8.

Early prediction of Mycobacterium tuberculosis transmission clusters using supervised learning models. (2024) Gharamaleki, O. G., Colijn, C., Sekirov, I., Johnston, J. C., and Sobkowiak, B. Sci Rep 14, 27652: https://doi.org/10.1038/s41598-024-78247-z.

Editorial: The evolution in pharmacology of infectious diseases: 2022. (2024) Porta, E. O. J., Saffaei, A., and Kalesh, K. Front Pharmacol 15, 1386077: https://doi.org/10.3389/fphar.2024.1386077.

The Effect of HIV on the Association of Hyperglycaemia and Active Tuberculosis in Zambia, a Case-Control Study. (2024) Bailey, S. L., Floyd, S., Cheeba-Lengwe, M., Maluzi, K., Chiwele-Kangololo, K., Kaluba-Milimo, D., Amofa-Sekyi, M., Yudkin, J. S., Godfrey-Faussett, P., and Ayles, H. J Epidemiol Glob Health 14, 914-922: https://doi.org/10.1007/s44197-024-00236-2.

Effect of interindividual variability in metabolic clearance and relative bioavailability on rifampicin exposure in tuberculosis patients with and without HIV co-infection: Does formulation quality matter? (2024) Nardotto, G. H. B., Svenson, E. M., Bollela, V. R., Rocha, A., Slavov, S. N., Ximenez, J. P. B., Della Pasqua, O., and Lanchote, V. L. Pharmaceutics 16 https://doi.org/10.3390/pharmaceutics16080970.

Effectiveness of the primary Bacillus Calmette-Guerin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data. (2024) Pelzer, P. T., Stuck, L., Martinez, L., Richards, A. S., Acuna-Villaorduna, C., Aronson, N. E., Bonnet, M., Carvalho, A. C., Chan, P. C., Huang, L. M., Fang, C. T., Churchyard, G., Corral-Londono, H. D., Datta, M., Espinal, M. A., Fielding, K., Fiore-Gartland, A. J., Garcia-Basteiro, A., Hanekom, W., Hatherill, M., Hill, P. C., Huerga, H., Jones-Lopez, E. C., Kritski, A., Mandalakas, A. M., Mangtani, P., Martins Netto, E., Mayanja, H., Mazahir, R., Murray, M., Rangaka, M., Scriba, T., Singh, J., Singh, S., Stein, C. M., Vekemans, J., Verhagen, L. M., Villalba, J. A., Wajja, A., Watson, B., White, R. G., and Cobelens, F. G. J. Lancet Microbe, 100961: https://doi.org/10.1016/j.lanmic.2024.100961.

The end of the road for blood RNA biomarkers as triage tests for symptomatic pulmonary tuberculosis among spontaneous sputum producers? (2024) Greenan-Barrett, J., Gupta, R. K., and Noursadeghi, M. Eur Respir J 64                      https://doi.org/10.1183/13993003.01365-2024.

Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial. (2024) Burke, R. M., Nyirenda, S. K., Mtenga, T., Twabi, H. H., Joekes, E., Walker, N. F., Nyirenda, R., Gupta-Wright, A., Nliwasa, M., Fielding, K., MacPherson, P., and Corbett, E. L. Clin Infect Dis https://doi.org/10.1093/cid/ciae273.

Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol. (2024) Neudecker, D., Fritschi, N., Sutter, T., Lu, L. L., Lu, P., Tebruegge, M., Santiago-Garcia, B., and Ritz, N. BMC Infect Dis 24, 481: https://doi.org/10.1186/s12879-024-09359-0.

Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa. (2024) Gupta-Wright, A., Ha, H., Abdulgadar, S., Crowder, R., Emmanuel, J., Mukwatamundu, J., Marcelo, D., Phillips, P. P. J., Christopher, D. J., Nhung, N. V., Theron, G., Yu, C., Nahid, P., Cattamanchi, A., Worodria, W., Denkinger, C. M., and Network, R. D. T. Lancet Glob Health 12, e226-e234: https://doi.org/10.1016/S2214-109X(23)00541-7.

Geographical targeting of active case finding for tuberculosis in Pakistan using hotspots identified by artificial intelligence software (SPOT-TB): study protocol for a pragmatic stepped wedge cluster randomised control trial. (2024) Zaidi, S. M. A., Mahfooz, A., Latif, A., Nawaz, N., Fatima, R., Rehman, F. U., Reza, T. E., and Emmanuel, F. BMJ Open Respir Res 11 https://doi.org/10.1136/bmjresp-2023-002079.

A Global Tuberculosis Dictionary: unified terms and definitions for the field of tuberculosis. (2024) Garcia-Basteiro, A. L., Ehrlich, J., Bonnet, M., Calnan, M., Graham, S. M., Hermans, S., Jarrett, A., Lewa, R., Mandalakas, A., Martinez, L., Migliori, G. B., Ong, C. W. M., Otero, L., Rangaka, M. X., Raviglione, M. C. B., Seaworth, B., Ssengooba, W., Theron, G., Trajman, A., and Behr, M. A. Lancet Glob Health 12, e737-e739: https://doi.org/10.1016/S2214-109X(24)00083-4.

Health and illness beliefs in adults with tuberculosis infection during the COVID-19 pandemic in the UK. (2024) Kilic, A., Clarke, A. L., Moon, Z., Hamada, Y., Chan, A. H. Y., Rahman, A., Layton, C., Griffiths, C. J., Zenner, D., Powell, E., Kunst, H., Lipman, M., Mandelbaum, M., Papineni, P., Tattersall, T., Duong, T., Abubakar, I., Rangaka, M. X., and Horne, R. Dialogues Health 4, 100162: https://doi.org/10.1016/j.dialog.2023.100162.

Heteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight? (2024) Park, M., Satta, G., and Haldar, P. Thorax 79, 599-600: https://doi.org/10.1136/thorax-2024-221409.

HIV and skin infections. (2024) Chandler, D. J., and Walker, S. L. Clin Dermatol 42, 155-168: https://doi.org/10.1016/j.clindermatol.2023.12.005.

HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015. (2024) Atkinson, A., Kraus, D., Banholzer, N., Miro, J. M., Reiss, P., Kirk, O., Mussini, C., Morlat, P., Podlekareva, D., Grant, A. D., Sabin, C., van der Valk, M., Le Moing, V., Meyer, L., Seng, R., Castagna, A., Obel, N., Antoniadou, A., Salmon, D., Zwahlen, M., Egger, M., de Wit, S., Furrer, H., Fenner, L., and Opportunistic Infections Project Working Group of the Collaboration of Observational, H. I. V. E. R. E. i. E. PLoS One 19, e0312035: https://doi.org/10.1371/journal.pone.0312035.

Identification and design of novel potential antimicrobial peptides targeting mycobacterial protein kinase PknB. (2024) Deka, H., Pawar, A., Battula, M., Ghfar, A. A., Assal, M. E., and Chikhale, R. V. Protein J 43, 858-868: https://doi.org/10.1007/s10930-024-10218-9.

Identification and molecular characterization of Mycobacterium bovis DNA in GeneXpert(R) MTB/RIF ultra-positive, culture-negative sputum from a rural community in South Africa. (2024) Goosen, W. J., Moodley, S., Ghielmetti, G., Moosa, Y., Zulu, T., Smit, T., Vukuzazi, T., Kleynhans, L., Kerr, T. J., Streicher, E. M., Hanekom, W. A., Warren, R. M., Wong, E. B., and Miller, M. A. One Health 18, 100702: https://doi.org/10.1016/j.onehlt.2024.100702.

Identification of mycobacterial thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies. (2024) Chikhale, R. V., Pawar, S. P., Kolpe, M. S., Shinde, O. D., Dahlous, K. A., Mohammad, S., Patil, P. C., and Bhowmick, S. Mol Divers 28, 1947-1964: https://doi.org/10.1007/s11030-024-10967-w.

Identification of Mycobacterium tuberculosis transcriptional repressor EthR inhibitors: Shape-based search and machine learning studies. (2024) Chikhale, R. V., Eldesoky, G. E., Kolpe, M. S., Suryawanshi, V. S., Patil, P. C., and Bhowmick, S. Heliyon 10, e26802: https://doi.org/10.1016/j.heliyon.2024.e26802.

Identification of novel hit molecules targeting M. tuberculosis polyketide synthase 13 by combining generative AI and physics-based methods. (2024) Chikhale, R. V., Choudhary, R., Malhotra, J., Eldesoky, G. E., Mangal, P., and Patil, P. C. Comput Biol Med 176, 108573: https://doi.org/10.1016/j.compbiomed.2024.108573.

Immunomonitoring in bladder cancer: a short report on stability of leukocytes and proteins in refrigerated urine samples. (2024) Sevko, A., Prevosto, C., Ragavan, S., Domingos-Pereira, S., Cesson, V., Carrera, M. B., Derre, L., and Deban, L. BMC Urol 24, 276: https://doi.org/10.1186/s12894-024-01673-8.

Immunopathology in human tuberculosis. (2024) Scriba, T. J., Maseeme, M., Young, C., Taylor, L., and Leslie, A. J. Sci Immunol 9, eado5951: https://doi.org/10.1126/sciimmunol.ado5951.

The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. (2024) Wijk, M., Gausi, K., Malatesta, S., Weber, S. E., Court, R., Myers, B., Carney, T., Parry, C. D. H., Horsburgh, C. R., White, L. F., Wiesner, L., Warren, R. M., Uren, C., McIlleron, H., Kloprogge, F., Denti, P., and Jacobson, K. R. J Antimicrob Chemother 79, 2022-2030: https://doi.org/10.1093/jac/dkae206.

The impact of physiological state and environmental stress on bacterial load estimation methodologies for Mycobacterium tuberculosis. (2024) Maitra, A., Wijk, M., Margaryan, H., Denti, P., McHugh, T. D., and Kloprogge, F. Sci Rep 14, 26108: https://doi.org/10.1038/s41598-024-74318-3.

Implications of subclinical tuberculosis for vaccine trial design and global effect. (2024) Churchyard, G. J., Houben, R., Fielding, K., Fiore-Gartland, A. L., Esmail, H., Grant, A. D., Rangaka, M. X., Behr, M., Garcia-Basteiro, A. L., Wong, E. B., Hatherill, M., Mave, V., Dagnew, A. F., Schmidt, A. C., Hanekom, W. A., Cobelens, F., and White, R. G. Lancet Microbe 5, 100895: https://doi.org/10.1016/S2666-5247(24)00127-7.

Improving the diagnosis of tuberculosis: old and new laboratory tools. (2024) Solanki, P., Elton, L., Honeyborne, I., Park, M., Satta, G., and McHugh, T. D. Expert Rev Mol Diagn 24, 487-496: https://doi.org/10.1080/14737159.2024.2362165.

Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers. (2024) Schiff, H. F., Walker, N. F., Ugarte-Gil, C., Tebruegge, M., Manousopoulou, A., Garbis, S. D., Mansour, S., Wong, P. H. M., Rockett, G., Piazza, P., Niranjan, M., Vallejo, A. F., Woelk, C. H., Wilkinson, R. J., Tezera, L. B., Garay-Baquero, D., and Elkington, P. JCI Insight 9 https://doi.org/10.1172/jci.insight.173273.

Integrating molecular microbial methods to improve faecal pollution management in rivers with designated bathing waters. (2024) Karunakaran, E., Battarbee, R., Tait, S., Brentan, B. M., Berney, C., Grinham, J., Herrero, M. A., Omolo, R., and Douterelo, I. Sci Total Environ 912, 168565: https://doi.org/10.1016/j.scitotenv.2023.168565.

Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease. (2024) Channon-Wells, S., Habgood-Coote, D., Vito, O., Galassini, R., Wright, V. J., Brent, A. J., Heyderman, R. S., Anderson, S. T., Eley, B., Martinon-Torres, F., Levin, M., Kaforou, M., Uk Kawasaki Disease Genetics, I. G., consortia, E., and Herberg, J. A. J Transl Med 22, 802: https://doi.org/10.1186/s12967-024-05241-4.

The International Consensus for Early TB framework (ICE-TB): Implications from a low-incidence setting. (2024) Denholm, J. T., Coussens, A., Houben, R., Horton, K. C., Wong, E. B., Kendall, E. A., Martinez, L., Musvosi, M., and Zaidi, S. M. A. Int J Tuberc Lung Dis 28, 381-386: https://doi.org/10.5588/ijtld.24.0081.

Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda. (2024) Mugenyi, L., Namuwenge, P. M., Ouma, S., Bakashaba, B., Nanfuka, M., Zech, J., Agaba, C., Mijumbi Ojok, A., Kaliba, F., Bossa Kato, J., Opito, R., Miya, Y., Katureebe, C., and Hirsch-Moverman, Y. PLoS One 19, e0296239: https://doi.org/10.1371/journal.pone.0296239.

Levofloxacin preventive treatment in children exposed to MDR tuberculosis. (2024) Hesseling, A. C., Purchase, S. E., Martinson, N. A., Fairlie, L., Schaaf, H. S., Brigden, J., Staples, S., Gibb, D. M., Garcia-Prats, A., Conradie, F., McGowan, C., Layton, C., Batist, E., Demers, A. M., Nyamathe, S., Frigati, L., Turner, R., Duong, T., and Seddon, J. A. N Engl J Med 391, 2315-2326: https://doi.org/10.1056/NEJMoa2314318.

Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis. (2024) Abdelgawad, N., Wasserman, S., Abdelwahab, M. T., Davis, A., Stek, C., Wiesner, L., Black, J., Meintjes, G., Wilkinson, R. J., and Denti, P. J Infect Dis 229, 1200-1208: https://doi.org/10.1093/infdis/jiad413.

Liposome-siderophore conjugates loaded with moxifloxacin serve as a model for drug delivery against Mycobacterium tuberculosis. (2024) Maringolo Ribeiro, C., Augusto Roque-Borda, C., Carolina Franzini, M., Fernanda Manieri, K., Manaia Demarqui, F., Leite Campos, D., Temperani Amaral Machado, R., Cristiane da Silva, I., Tavares Luiz, M., Delello Di Filippo, L., Bento da Silva, P., Cristina Oliveira da Rocha, M., Nair Bao, S., Masci, D., Fernandes, G. F. S., Castagnolo, D., Chorilli, M., and Rogerio Pavan, F. Int J Pharm 655, 124050: https://doi.org/10.1016/j.ijpharm.2024.124050.

Localised erythema nodosum leprosum-A rare entity managed with thalidomide. (2024) Patel, C., De Barros, B., and Walker, S. L. Skin Health Dis 4, e339: https://doi.org/10.1002/ski2.339.

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial. (2024) Goodall, R. L., Nunn, A. J., Meredith, S. K., Bayissa, A., Bhatnagar, A. K., Chiang, C. Y., Conradie, F., Gopalan, N., Gurumurthy, M., Kirenga, B., Kiria, N., Meressa, D., Moodliar, R., Ngubane, N., Rassool, M., Sanders, K., Solanki, R., Squire, S. B., Teferi, M., Torrea, G., Tsogt, B., Tudor, E., Van Deun, A., Rusen, I. D., and collaborators, S. s. Lancet Respir Med 12, 975-987: https://doi.org/10.1016/S2213-2600(24)00186-3.

Machine learning assisted methods for the identification of low toxicity inhibitors of Enoyl-Acyl Carrier Protein Reductase (InhA). (2024) Chikhale, R. V., Abdelghani, H. T. M., Deka, H., Pawar, A. D., Patil, P. C., and Bhowmick, S. Comput Biol Chem 110, 108034: https://doi.org/10.1016/j.compbiolchem.2024.108034.

Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. (2024) Fuller, N. M., McQuaid, C. F., Harker, M. J., Weerasuriya, C. K., McHugh, T. D., and Knight, G. M. PLoS Pathog 20, e1011574: https://doi.org/10.1371/journal.ppat.1011574.

Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia. (2024) Gosce, L., Tadesse, A. W., Foster, N., van Kalmthout, K., Rest, J. V., van der Wal, J., Harker, M. J., Madden, N., Abdurhman, T., Gadissa, D., Bedru, A., Dube, T. N., Alacapa, J., Mganga, A., Deyanova, N., Charalambous, S., Letta, T., Jerene, D., White, R., Fielding, K. L., Houben, R. M., and McQuaid, C. F. BMJ Glob Health 9 https://doi.org/10.1136/bmjgh-2024-016997.

The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif. (2024) Neumann, M., Reimann, M., Chesov, D., Popa, C., Dragomir, A., Popescu, O., Munteanu, R., Holscher, A., Honeyborne, I., Heyckendorf, J., Lange, C., Holscher, C., and Kalsdorf, B. J Infect 90, 106399: https://doi.org/10.1016/j.jinf.2024.106399.

Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture. (2024) Schurz, H., Naranbhai, V., Yates, T. A., Gilchrist, J. J., Parks, T., Dodd, P. J., Moller, M., Hoal, E. G., Morris, A. P., Hill, A. V. S., and International Tuberculosis Host Genetics, C. Elife 13 https://doi.org/10.7554/eLife.84394.

Mycobacterial FtsEX-RipC interaction is required for normal growth and cell morphology in rifampicin and low ionic strength conditions. (2024) Samuels, V., Mulelu, A. E., Ndlovu, H., and Marakalala, M. J. Microbiol Spectr 12, e0251523: https://doi.org/10.1128/spectrum.02515-23.

The Mycobacterium tuberculosis cell wall: An alluring drug target for developing newer anti-TB Drugs-A perspective. (2024) Chauhan, M., Barot, R., Yadav, R., Joshi, K., Mirza, S., Chikhale, R., Srivastava, V. K., Yadav, M. R., and Murumkar, P. R. Chem Biol Drug Des 104, e14612: https://doi.org/10.1111/cbdd.14612.

Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model. (2024) Ahmed, M., Tezera, L. B., Herbert, N., Chambers, M., Reichmann, M. T., Nargan, K., Kloverpris, H., Karim, F., Hlatshwayo, M., Madensein, R., Habesh, M., Hoque, M., Steyn, A. J. C., Elkington, P. T., and Leslie, A. J. Front Immunol 15, 1360412: https://doi.org/10.3389/fimmu.2024.1360412.

Need for high-resolution observational cohort studies to understand the natural history of tuberculosis. (2024) Larsson, L., Calderwood, C. J., Gupta, R. K., Khosa, C., and Kranzer, K. Lancet Microbe 5, 100908: https://doi.org/10.1016/S2666-5247(24)00140-X.

Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management. (2024) Kumar, K., Ponnuswamy, A., Capstick, T. G., Chen, C., McCabe, D., Hurst, R., Morrison, L., Moore, F., Gallardo, M., Keane, J., Harwood, S., Sinnett, T., Bryant, S., Breen, R., Kon, O. M., Lipman, M., Loebinger, M. R., and Dhasmana, D. J. Clin Med (Lond) 24, 100017: https://doi.org/10.1016/j.clinme.2024.100017.

A novel regulatory interplay between atypical B12 riboswitches and uORF translation in Mycobacterium tuberculosis. (2024) Kipkorir, T., Polgar, P., Barker, D., D'Halluin, A., Patel, Z., and Arnvig, K. B. Nucleic Acids Res 52, 7876-7892: https://doi.org/10.1093/nar/gkae338.

A novel, nonaquatic zoonotic transmission of Mycobacterium marinum. (2024) Kravvas, G., Aboukhatwah, N., Meghoma, L., Vilenchik, V., Oxley, J., and Keith, D. Case Rep Infect Dis 2024, 2767290: https://doi.org/10.1155/crdi/2767290.

Nutritional supplementation for tuberculosis prevention: the RATIONS trial. (2024) Rickman, H. M., and Yates, T. A. Lancet 404, 1522: https://doi.org/10.1016/S0140-6736(24)02090-7.

Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence. (2024) Matteelli, A., Churchyard, G., Cirillo, D., den Boon, S., Falzon, D., Hamada, Y., Houben, R., Kanchar, A., Kritski, A., Kumar, B., Miller, C., Menzies, D., and Masini, T. PLOS Glob Public Health 4, e0003306: https://doi.org/10.1371/journal.pgph.0003306.

Perspectives on development and advancement of new tuberculosis vaccines. (2024) da Costa, C., Benn, C. S., Nyirenda, T., Mpabalwani, E., Grewal, H. M. S., Ahmed, R., Kapata, N., Nyasulu, P. S., Maeurer, M., Hui, D. S., Goletti, D., and Zumla, A. Int J Infect Dis 141S, 106987: https://doi.org/10.1016/j.ijid.2024.106987.

Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy. (2024) Qadir, M., Faryal, R., Khan, M. T., Khan, S. A., Zhang, S., Li, W., Wei, D. Q., Tahseen, S., and McHugh, T. D. Microbiol Spectr 12, e0163123: https://doi.org/10.1128/spectrum.01631-23.

Phylogenetic survival analysis. (2024) Torres Ortiz, A., and Grandjean, L. Methods Mol Biol 2833, 121-128: https://doi.org/10.1007/978-1-0716-3981-8_12.

Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study. (2024) Reeve, B. W. P., Ndlangalavu, G., Mishra, H., Palmer, Z., Tshivhula, H., Rockman, L., Naidoo, S., Mbu, D. L., Naidoo, C. C., Derendinger, B., Walzl, G., Malherbe, S. T., van Helden, P. D., Semitala, F. C., Yoon, C., Gupta, R. K., Noursadeghi, M., Warren, R. M., and Theron, G. Lancet Glob Health 12, e793-e803: https://doi.org/10.1016/S2214-109X(24)00052-4.

Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017-2023. (2024) Ferran, E., Chan, C., Sheikh, N., Dedicoat, M., Alexander, E., Gibertoni-Cruz, A., Brown, J., Robinson, E., and Lipman, M. Clin Infect Dis https://doi.org/10.1093/cid/ciae560.

Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis. (2024) Hamada, Y., Quartagno, M., Malik, F., Ntshamane, K., Tisler, A., Gaikwad, S., Acuna-Villaorduna, C., Bhavani, P. K., Alisjahbana, B., Ronacher, K., Apriani, L., Becerra, M., Chu, A. L., Creswell, J., Diaz, G., Ferro, B. E., Galea, J. T., Grandjean, L., Grewal, H. M. S., Gupta, A., Jones-Lopez, E. C., Kleynhans, L., Lecca, L., MacPherson, P., Murray, M., Marin, D., Restrepo, B. I., Shivakumar, S., Shu, E., Sivakumaran, D., Vo, L. N. Q., Webb, E. L., Copas, A., Abubakar, I., and Rangaka, M. X. Trop Med Int Health 29, 768-780: https://doi.org/10.1111/tmi.14038.

Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis. (2024) Stuck, L., Klinkenberg, E., Abdelgadir Ali, N., Basheir Abukaraig, E. A., Adusi-Poku, Y., Alebachew Wagaw, Z., Fatima, R., Kapata, N., Kapata-Chanda, P., Kirenga, B., Maama-Maime, L. B., Mfinanga, S. G., Moyo, S., Mvusi, L., Nandjebo, N., Nguyen, H. V., Nguyen, H. B., Obasanya, J., Adedapo Olufemi, B., Patrobas Dashi, P., Raleting Letsie, T. J., Ruswa, N., Rutebemberwa, E., Senkoro, M., Sivanna, T., Yuda, H. C., Law, I., Onozaki, I., Tiemersma, E., Cobelens, F., and sc, T. B. M. I. G. Lancet Infect Dis 24, 726-736: https://doi.org/10.1016/S1473-3099(24)00011-2.

Preventive therapy: can tuberculosis efforts learn anything from the leprosy approach? (2024) Wakerley, D., de Barros, B., Moore, D. A. J., Walker, S. L., Walker, T., and Esmail, H. Lancet Glob Health 12, e1393-e1394: https://doi.org/10.1016/S2214-109X(24)00254-7.

Protective role of Bacillus Calmette-Guerin vaccine in Alzheimer's disease progression: A systematic review and meta-analysis. (2024) Umar, T. P., Jain, N., Stevanny, B., Javed, B., Priandhana, A., Siburian, R., and Kostiks, A. Heliyon 10, e27425: https://doi.org/10.1016/j.heliyon.2024.e27425.

Providing personalised care for people with tuberculosis: an evaluation of enhanced case management in a UK TB Network 2013 to 2021. (2024) Crocker-Buque, T., Hayden, H., White, J., Dekoningh, J., Belton, M., Boparai, N., Brown, J., Brown, M., Hawley, D., Lozewicz, S., Miller, R., Moores, R., Moshal, K., Potter, J., Lipman, M., and North Central London Tuberculosis, S. JRSM Open 15, 20542704241290486: https://doi.org/10.1177/20542704241290486.

A publicly accessible global data repository - the WHO TB-IPD platform. (2024) Goodall, R. L., Fabiane, S. M., Hakiman, A., Crook, A. M., Mirzayev, F., Schumacher, S., and Rangaka, M. X. IJTLD Open 1, 151-153: https://doi.org/10.5588/ijtldopen.24.0131.

Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-up. (2024) Walker, E. F., Flook, M., Rodger, A. J., Fielding, K. L., and Stagg, H. R. BMJ Open Respir Res 11 https://doi.org/10.1136/bmjresp-2023-001894.

Quantitative MODS-Wayne assay for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis from sputum samples. (2024) Toscano-Guerra, E., Alcantara, R., Untiveros, K. L., Gilman, R., Grandjean, L., Zimic, M., and Sheen, P. Microbiol Spectr 12, e0047124: https://doi.org/10.1128/spectrum.00471-24.

Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen. (2024) Chiang, C. Y., Bern, H., Goodall, R., Chien, S. T., Rusen, I. D., Nunn, A., and Collaborators, S. S.-s. BMC Infect Dis 24, 144: https://doi.org/10.1186/s12879-024-09039-z.

Resolution of tuberculosis blood RNA signatures fails to discriminate persistent sputum culture positivity after 8 weeks of anti-tuberculous treatment. (2024) Calderwood, C. J., Sanchez Martinez, A., Greenan-Barrett, J., Turner, C. T., Oguti, B., Roe, J. K., Gupta, R., Martineau, A. R., and Noursadeghi, M. Eur Respir J 64 https://doi.org/10.1183/13993003.00457-2024.

Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe. (2024) Johansen, I. S., Roen, A., Kraef, C., Martin-Iguacel, R., Nemeth, J., Fenner, L., Zangerle, R., Llibre, J. M., Miller, R. F., Suarez, I., de Wit, S., Wit, F., Mussini, C., Saracino, A., Canetti, D., Volny-Anne, A., Jaschinski, N., Neesgaard, B., Ryom, L., Peters, L., Garges, H. P., Rooney, J. F., Podlekareva, D., Mocroft, A., Kirk, O., and group, R. S. Int J Infect Dis 147, 107199: https://doi.org/10.1016/j.ijid.2024.107199.

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial. (2024) Heinrich, N., de Jager, V., Dreisbach, J., Gross-Demel, P., Schultz, S., Gerbach, S., Kloss, F., Dawson, R., Narunsky, K., Matt, L., Wildner, L., McHugh, T. D., Fuhr, U., Aldana, B. H., Mouhdad, C., Brake, L. T., Boeree, M. J., Aarnoutse, R. E., Svensson, E. M., Gong, X., P, P. J. P., Diacon, A. H., Hoelscher, M., and Pan, A.-T. B. c. Lancet Microbe, 100952: https://doi.org/10.1016/j.lanmic.2024.07.015.

Screening for latent tuberculosis in migrants-status quo and future challenges. (2024) Petersen, E., Al-Abri, S., Al-Jardani, A., Memish, Z. A., Aklillu, E., Ntoumi, F., Mwaba, P., Wejse, C., Zumla, A., and Al-Yaquobi, F. Int J Infect Dis 141S, 107002: https://doi.org/10.1016/j.ijid.2024.107002.

Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings. (2024) van Geuns, D., Arts, R. J. W., de Vries, G., Wit, F., Degtyareva, S. Y., Brown, J., Pareek, M., Lipman, M., and van Crevel, R. AIDS 38, 193-205: https://doi.org/10.1097/QAD.0000000000003747.

Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches. (2024) Campos, D. L., Canales, C. S. C., Demarqui, F. M., Fernandes, G. F. S., Dos Santos, C. G., Prates, J. L. B., da Silva, I. G. M., Barros-Cordeiro, K. B., Bao, S. N., de Andrade, L. N., Abichabki, N., Zacharias, L. V., de Campos, M. M. A., Dos Santos, J. L., and Pavan, F. R. Front Microbiol 15, 1487829: https://doi.org/10.3389/fmicb.2024.1487829.

Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB study. (2024) Olbrich, L., Franckling-Smith, Z., Larsson, L., Sabi, I., Ntinginya, N. E., Khosa, C., Banze, D., Nliwasa, M., Corbett, E. L., Semphere, R., Verghese, V. P., Michael, J. S., Ninan, M. M., Saathoff, E., McHugh, T. D., Razid, A., Graham, S. M., Song, R., Nabeta, P., Trollip, A., Nicol, M. P., Hoelscher, M., Geldmacher, C., Heinrich, N., Zar, H. J., and RaPaed, A.-T. B. c. Lancet Infect Dis https://doi.org/10.1016/S1473-3099(24)00494-8.

Shifting patterns and competing explanations for infectious disease priority in global health agenda setting arenas. (2024) Smith, S. L., Parashar, R., Nanda, S., Shiffman, J., Shroff, Z. C., Shawar, Y. R., and Hamunakwadi, D. L. Health Policy Plan 39, 805-818: https://doi.org/10.1093/heapol/czae035.

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial. (2024) Nyang'wa, B. T., Berry, C., Kazounis, E., Motta, I., Parpieva, N., Tigay, Z., Moodliar, R., Dodd, M., Solodovnikova, V., Liverko, I., Rajaram, S., Rassool, M., McHugh, T., Spigelman, M., Moore, D. A., Ritmeijer, K., du Cros, P., Fielding, K., and team, T.-P. Lancet Respir Med 12, 117-128: https://doi.org/10.1016/S2213-2600(23)00389-2.

Subclinical tuberculosis linkage to care and completion of treatment following community-based screening in rural South Africa. (2024) Sifumba, Z., Claassen, H., Olivier, S., Khan, P., Ngubane, H., Bhengu, T., Zulu, T., Sithole, M., Gareta, D., Vukuzazi, T., Moosa, M. S., Hanekom, W. A., Bassett, I. V., and Wong, E. B. BMC Glob Public Health 2, 30: https://doi.org/10.1186/s44263-024-00059-0.

Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis. (2024) Shao, Z., Tam, K. K., Achalla, V. P. K., Woon, E. C. Y., Mason, A. J., Chow, S. F., Yam, W. C., and Lam, J. K. W. Int J Pharm 654, 123960: https://doi.org/10.1016/j.ijpharm.2024.123960.

Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations. (2024) Wang, Q., Cao, Y., Liu, X., Fu, Y., Zhang, J., Zhang, Y., Zhang, L., Wei, X., and Yang, L. PLoS Negl Trop Dis 18, e0012136: https://doi.org/10.1371/journal.pntd.0012136.

Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays. (2024) Gosce, L., Allel, K., Hamada, Y., Surkova, E., Kontsevaya, I., Wang, T. T., Liu, W. H., Matveev, A., Ziganshina, L. E., Korobitsyn, A., Ismail, N., Bashir, S., Denkinger, C. M., Abubakar, I., White, P. J., and Rangaka, M. X. PLOS Glob Public Health 4, e0003655: https://doi.org/10.1371/journal.pgph.0003655.

Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2. (2024) Nichols, B. E., de Nooy, A., Cassim, N., Hans, L., da Silva, M. P., Chetty, K., Grantz, K. H., Han, A. X., Phillips, A. N., Jamieson, L., Scott, L. E., and Stevens, W. S. BMJ Glob Health 9 https://doi.org/10.1136/bmjgh-2024-015830.

Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys: Time for household-wide interventions? (2024) Hamada, Y., Quartagno, M., Law, I., Malik, F., Bonsu, F. A., Adetifa, I. M. O., Adusi-Poku, Y., D'Alessandro, U., Bashorun, A. O., Begum, V., Lolong, D. B., Boldoo, T., Dlamini, T., Donkor, S., Dwihardiani, B., Egwaga, S., Farid, M. N., Garfin, A., Gaviola, D. M. G., Husain, M. M., Ismail, F., Kaggwa, M., Kamara, D. V., Kasozi, S., Kaswaswa, K., Kirenga, B., Klinkenberg, E., Kondo, Z., Lawanson, A., Macheque, D., Manhica, I., Maama-Maime, L. B., Mfinanga, S., Moyo, S., Mpunga, J., Mthiyane, T., Mustikawati, D. E., Mvusi, L., Nguyen, H. B., Nguyen, H. V., Pangaribuan, L., Patrobas, P., Rahman, M., Rahman, M., Rahman, M. S., Raleting, T., Riono, P., Ruswa, N., Rutebemberwa, E., Rwabinumi, M. F., Senkoro, M., Sharif, A. R., Sikhondze, W., Sismanidis, C., Sovd, T., Stavia, T., Sultana, S., Suriani, O., Thomas, A. M., Tobing, K., Van der Walt, M., Walusimbi, S., Zaman, M. M., Floyd, K., Copas, A., Abubakar, I., and Rangaka, M. X. PLOS Glob Public Health 4, e0002596: https://doi.org/10.1371/journal.pgph.0002596.

Treatment of latent tuberculosis infection in migrants in primary care versus secondary care. (2024) Burman, M., Zenner, D., Copas, A. J., Gosce, L., Haghparast-Bidgoli, H., White, P. J., Hickson, V., Greyson, O., Trathen, D., Ashcroft, R., Martineau, A. R., Abubakar, I., Griffiths, C. J., and Kunst, H. Eur Respir J 64https://doi.org/10.1183/13993003.01733-2023.

Treatment preferences among people at risk of developing tuberculosis: A discrete choice experiment. (2024) Kamchedzera, W., Quaife, M., Msukwa-Panje, W., Burke, R. M., Macpherson, L., Kumwenda, M., Twabi, H. H., Quartagno, M., MacPherson, P., and Esmail, H. PLOS Glob Public Health 4, e0002804: https://doi.org/10.1371/journal.pgph.0002804.

Tribbles1 is host protective during in vivo mycobacterial infection. (2024) Hammond, F. R., Lewis, A., Pollara, G., Tomlinson, G. S., Noursadeghi, M., Kiss-Toth, E., and Elks, P. M. Elife 13 https://doi.org/10.7554/eLife.95980.

Tuberculin skin test surveys and the Annual Risk of Tuberculous Infection in school children in Northern KwaZulu-Natal. (2024) Yates, T. A., Cebekhulu, S., Mthethwa, M., Fourie, P. B., Newell, M. L., Abubakar, I., and Tanser, F. PLOS Glob Public Health 4, e0003263: https://doi.org/10.1371/journal.pgph.0003263.

Tuberculosis and incarceration: uncovering the broader picture. (2024) Schwalb, A., Gosce, L., and Houben, R. Lancet Public Health 9, e832-e833: https://doi.org/10.1016/S2468-2667(24)00224-X.

Tuberculosis disease in immunocompromised children and adolescents: A pediatric tuberculosis network european trials group multicenter case-control study. (2024) Rodriguez-Molino, P., Tebruegge, M., Noguera-Julian, A., Neth, O., Fidler, K., Brinkmann, F., Sainz, T., Ivaskeviciene, I., Ritz, N., Brito, M. J., Milheiro Silva, T., Chechenieva, V., Serdiuk, M., Lancella, L., Russo, C., Soler-Garcia, A., Navarro, M. L., Krueger, R., Feiterna-Sperling, C., Starshinova, A., Hiteva, A., Hoffmann, A., Kalibatas, P., Lo Vecchio, A., Scarano, S. M., Bustillo, M., Blazquez Gamero, D., Espiau, M., Buonsenso, D., Falcon, L., Turnbull, L., Colino, E., Rueda, S., Buxbaum, C., Carazo, B., Alvarez, C., Dapena, M., Piqueras, A., Velizarova, S., Ozere, I., Gotzinger, F., Pareja, M., Garrote Llanos, M. I., Soto, B., Rodriguez Martin, S., Korta, J. J., Perez-Gorricho, B., Herranz, M., Hernandez-Bartolome, A., Diaz-Almiron, M., Kohns Vasconcelos, M., Ferreras-Antolin, L., and Santiago-Garcia, B. Clin Infect Dis 79, 215-222: https://doi.org/10.1093/cid/ciae158.

Tuberculosis in adult migrants in Europe: a TBnet consensus statement. (2024) Kunst, H., Lange, B., Hovardovska, O., Bockey, A., Zenner, D., Andersen, A. B., Hargreaves, S., Pareek, M., Friedland, J. S., Wejse, C., Bothamley, G., Guglielmetti, L., Chesov, D., Tiberi, S., Matteelli, A., Mandalakas, A. M., Heyckendorf, J., Eimer, J., Malhotra, A., Zamora, J., Vasiliu, A., Lange, C., and Tbnet Eur Respir J https://doi.org/10.1183/13993003.01612-2024.

Tuberculosis prevention: current strategies and future directions. (2024) Vasiliu, A., Martinez, L., Gupta, R. K., Hamada, Y., Ness, T., Kay, A., Bonnet, M., Sester, M., Kaufmann, S. H. E., Lange, C., and Mandalakas, A. M. Clin Microbiol Infect 30, 1123-1130: https://doi.org/10.1016/j.cmi.2023.10.023.

Tuberculosis treatment monitoring tests during routine practice: study design guidance. (2024) MacLean, E. L., Zimmer, A. J., den Boon, S., Gupta-Wright, A., Cirillo, D. M., Cobelens, F., Gillespie, S. H., Nahid, P., Phillips, P. P., Ruhwald, M., and Denkinger, C. M. Clin Microbiol Infect 30, 481-488: https://doi.org/10.1016/j.cmi.2023.12.027.

Tuberculosis-associated hemophagocytic lymphohistiocytosis: diagnostic challenges and determinants of outcome. (2024) Kurver, L., Seers, T., van Dorp, S., van Crevel, R., Pollara, G., and van Laarhoven, A. Open Forum Infect Dis 11, ofad697: https://doi.org/10.1093/ofid/ofad697.

T-wave morphology abnormalities in the STREAM stage 1 trial. (2024) Hughes, G., Young, W. J., Bern, H., Crook, A., Lambiase, P. D., Goodall, R. L., Nunn, A. J., and Meredith, S. K. Expert Opin Drug Saf 23, 469-476: https://doi.org/10.1080/14740338.2024.2322116.

Understanding the potential role of whole genome sequencing (WGS) in managing patients with gonorrhoea: A systematic review of WGS use on human pathogens in individual patient care. (2024) Osman, R., Dema, E., David, A., Hughes, G., Field, N., Cole, M., Didelot, X., and Saunders, J. J Infect 88, 106168: https://doi.org/10.1016/j.jinf.2024.106168.

Unveiling the complexity of rifampicin drug susceptibility testing in Mycobacterium tuberculosis: comparative analysis with next-generation sequencing. (2024) Qadir, M., Khan, M. T., Khan, S. A., Akram, M., Canseco, J. O., Faryal, R., Wei, D. Q., and Tahseen, S. J Med Microbiol 73 https://doi.org/10.1099/jmm.0.001884.

Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis. (2024) Sileshi, T., Makonnen, E., Telele, N. F., Barclay, V., Zumla, A., and Aklillu, E. Infect Dis (Lond) 56, 308-319: https://doi.org/10.1080/23744235.2024.2309348.

What is next for BCG revaccination to prevent tuberculosis? (2024) White, R. G., Fiore-Gartland, A. J., Hanekom, W. A., Vekemans, J., Garcia-Basteiro, A. L., Churchyard, G., Rangaka, M. X., Frick, M., Behr, M. A., Hill, P. C., and Mave, V. Lancet Respir Med 12, e7-e8: https://doi.org/10.1016/S2213-2600(24)00009-2.

World Tuberculosis Day 2024 theme "Yes! We can end TB" can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease. (2024) Goletti, D., Al-Abri, S., Migliori, G. B., Arlehamn, C. L., Haldar, P., Sundling, C., da Costa, C., To, K. W., Martineau, A. R., Petersen, E., Zumla, A., and Shan Lee, S. Int J Infect Dis 141S, 106993: https://doi.org/10.1016/j.ijid.2024.106993.

Yield of routine mycobacterial culture of osteoarticular specimens in a tertiary orthopaedic hospital in England, 2017-2022. (2024) Yates, T. A., Vahesan, O., Warren, S., and Scobie, A. J Bone Jt Infect 9, 217-223: https://doi.org/10.5194/jbji-9-217-2024.

Other Outputs

Blog: UKAPTB meeting: Strengthening partnerships across the UK to end TB. Jess Potter.

Back to top

Go to main Research page / previous years